Key facts
- Grow Therapy’s last known valuation is $3.0B (Mar 2026).
- It has raised $328.1M; the latest was Later Stage VC ($150.0M) in Mar 2026.
- Notable investors include Sequoia Capital, Mana Ventures, Menlo Ventures, Village Global, Harvard Innovation Launch Lab — 36 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 36 names
- ·Watchlist + deal alerts for Grow Therapy
- ·The full record, as it builds
Funding rounds
No funding rounds for Grow Therapy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Grow Therapy
Developer of a mental healthcare platform designed to connect individuals with licensed therapists and psychiatric providers. The company offers digital tools for provider matching, appointment scheduling, insurance verification, and practice management support, enabling patients to access therapy services and clinicians to manage their practice operations.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 120
- Website
- growtherapy.com/
- Ownership
- Privately Held (backing)
Grow Therapy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Grow Therapy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Grow Therapy in its N-PORT filings yet. We sweep new filings monthly.